Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial.

Jan MaláskaJan StašekFrantišek DuškaMartin BalíkJan MácaJan HrudaTomáš VymazalOlga KlementováJan ZatloukalTomáš GabrhelíkPavel NovotnýRegina DemlováJana KubátováJana VinklerováAdam SvobodníkMilan KratochvílJozef KlučkaRoman GálMervyn Singernull null

Published in: Trials (2022)

EudraCT No. 2020-005887-70. ClinicalTrials.gov NCT04663555. Registered on December 11, 2020.

Keyphrases

study protocol
open label
randomized controlled trial
phase iii
phase ii
coronavirus disease
sars cov
acute respiratory distress syndrome
clinical trial
phase ii study
low dose
extracorporeal membrane oxygenation
high dose
mechanical ventilation
placebo controlled
respiratory syndrome coronavirus